Clinical Trial Update: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN) [Phase 3]

View source ↗

Summary

Phase 3 GLISTEN trial evaluating linerixibat for pruritus in primary biliary cholangitis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Linerixibat (linerixibat)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pruritus | Phase 3 | Status: COMPLETED | Results posted: 2025-07-22